- Report
- February 2026
- 189 Pages
Global
From €4331EUR$4,799USD£3,763GBP
- Report
- May 2025
- 628 Pages
Global
From €6453EUR$7,150USD£5,606GBP
- Report
- February 2026
- 255 Pages
Global
From €3745EUR$4,150USD£3,254GBP
- Report
- October 2025
- 164 Pages
Global
From €4196EUR$4,650USD£3,646GBP
- Report
- June 2025
- 140 Pages
Global
From €3609EUR$3,999USD£3,135GBP
- Report
- January 2026
- 120 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- August 2025
- 250 Pages
Global
From €2256EUR$2,500USD£1,960GBP
- Report
- August 2025
- 234 Pages
Global
From €2256EUR$2,500USD£1,960GBP
- Report
- September 2025
- 139 Pages
Global
From €4196EUR$4,650USD£3,646GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- April 2025
- 175 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- April 2025
- 200 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- March 2026
- 142 Pages
Global
From €5279EUR$5,850USD£4,587GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more